Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C10H14N2O2 |
| Molecular Weight | 194.2304 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C=CC[C@@]12CCCN1C(=O)CNC2=O
InChI
InChIKey=WVKCGUOWPZAROG-JTQLQIEISA-N
InChI=1S/C10H14N2O2/c1-2-4-10-5-3-6-12(10)8(13)7-11-9(10)14/h2H,1,3-7H2,(H,11,14)/t10-/m0/s1
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
706019
Created by
admin on Mon Mar 31 22:49:32 GMT 2025 , Edited by admin on Mon Mar 31 22:49:32 GMT 2025
|
||
|
FDA ORPHAN DRUG |
706119
Created by
admin on Mon Mar 31 22:49:32 GMT 2025 , Edited by admin on Mon Mar 31 22:49:32 GMT 2025
|
||
|
FDA ORPHAN DRUG |
835121
Created by
admin on Mon Mar 31 22:49:32 GMT 2025 , Edited by admin on Mon Mar 31 22:49:32 GMT 2025
|
||
|
FDA ORPHAN DRUG |
705719
Created by
admin on Mon Mar 31 22:49:32 GMT 2025 , Edited by admin on Mon Mar 31 22:49:32 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
300000025859
Created by
admin on Mon Mar 31 22:49:32 GMT 2025 , Edited by admin on Mon Mar 31 22:49:32 GMT 2025
|
PRIMARY | |||
|
847952-38-9
Created by
admin on Mon Mar 31 22:49:32 GMT 2025 , Edited by admin on Mon Mar 31 22:49:32 GMT 2025
|
PRIMARY | |||
|
2T1HU6069S
Created by
admin on Mon Mar 31 22:49:32 GMT 2025 , Edited by admin on Mon Mar 31 22:49:32 GMT 2025
|
PRIMARY | |||
|
DB15601
Created by
admin on Mon Mar 31 22:49:32 GMT 2025 , Edited by admin on Mon Mar 31 22:49:32 GMT 2025
|
PRIMARY | |||
|
11735696
Created by
admin on Mon Mar 31 22:49:32 GMT 2025 , Edited by admin on Mon Mar 31 22:49:32 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
